This is a company with very volatile returns over the past few years ranging from + 70% to - 70 %. It is a tough one to analyze from a fundamental perspective and I would put this into the "too hard to analyze" category and look for other easier ones
We just have to monitor the next few quarterly results. It's still too early to say it will bust or boom. There has been more foreign buying recently. Let's wait and see. No harm waiting for a couple more years if you have holding power.
The healthcare industry in China has great potential. The focus is on high quality development. Ucrest's collaboration with a China company in the AI 3D printing is a positive for the company's prospect.
The prospects are good. It will take time for this stock to appreciate in value. There's risk and reward. If you have holding power and you believe there's value then you wait. If not you leave.
There are many shares exchanging hands. A lot of foreign transactions lately during this pp period. We just have to wait for the outcome. If you look at the trade summary, there seems to be a cap to the price so that it doesn't move much from the median price.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
HappiGoLucky
45 posts
Posted by HappiGoLucky > 2023-09-25 15:41 | Report Abuse
0.20 coming?